OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
2.270
-0.050 (-2.16%)
Sep 3, 2025, 11:23 AM - Market open

OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $85.38 million. The enterprise value is $84.56 million.

Market Cap85.38M
Enterprise Value 84.56M

Important Dates

The last earnings date was Friday, July 18, 2025, before market open.

Earnings Date Jul 18, 2025
Ex-Dividend Date n/a

Share Statistics

OKYO Pharma has 37.61 million shares outstanding. The number of shares has increased by 34.57% in one year.

Current Share Class 37.61M
Shares Outstanding 37.61M
Shares Change (YoY) +34.57%
Shares Change (QoQ) +35.24%
Owned by Insiders (%) 33.31%
Owned by Institutions (%) 7.37%
Float 25.08M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio 0.40
Quick Ratio 0.37
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.15

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -169.87%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 127.79%
Revenue Per Employee n/a
Profits Per Employee -$1.18M
Employee Count4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -3.26M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +93.33% in the last 52 weeks. The beta is -4.20, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y) -4.20
52-Week Price Change +93.33%
50-Day Moving Average 2.69
200-Day Moving Average 1.66
Relative Strength Index (RSI) 40.80
Average Volume (20 Days) 135,006

Short Selling Information

The latest short interest is 15,495, so 0.04% of the outstanding shares have been sold short.

Short Interest 15,495
Short Previous Month 77,253
Short % of Shares Out 0.04%
Short % of Float 0.06%
Short Ratio (days to cover) 0.07

Income Statement

Revenue n/a
Gross Profit -4.84M
Operating Income -7.09M
Pretax Income -13.28M
Net Income -4.71M
EBITDA -7.09M
EBIT -7.09M
Earnings Per Share (EPS) -$0.12
Full Income Statement

Balance Sheet

The company has $1.56 million in cash and n/a in debt, giving a net cash position of $1.56 million or $0.04 per share.

Cash & Cash Equivalents 1.56M
Total Debt n/a
Net Cash 1.56M
Net Cash Per Share $0.04
Equity (Book Value) -5.55M
Book Value Per Share -0.15
Working Capital -5.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.81 million and capital expenditures -$1,208, giving a free cash flow of -$1.81 million.

Operating Cash Flow -1.81M
Capital Expenditures -1,208
Free Cash Flow -1.81M
FCF Per Share -$0.05
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -34.57%
Shareholder Yield -34.57%
Earnings Yield -5.46%
FCF Yield -2.10%

Analyst Forecast

The average price target for OKYO Pharma is $7.00, which is 208.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 208.37%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:65.

Last Split Date May 22, 2023
Split Type Reverse
Split Ratio 1:65

Scores

Altman Z-Score n/a
Piotroski F-Score 2